Table 1

Study characteristics and screening methods used to select candidates for TA

AuthorYearStudy countryStudy periodStudy designStudy inclusion characteristics for screeningScreening methods used to determine eligibility for TA
Banerjee et al92020IndiaFebruary 2016–July 2017Prospective randomised trial30–60 years old, non-pregnant, previously unscreened womenVIA or HPV
Campbell et al232016MalawiOctober 2013–March 2015Quality improvement16–86 years old, non-pregnantVIA
Chigbu et al182020Nigeria2014–2018Prospective analytical/comparative studyWomenVIA and colposcopy
Duan et al282021ChinaMay 2017–May 2018Prospective randomised trial20–49 years old, non-pregnant, negative endocervical curettage and no vaginal lesions, women were excluded if they had a history of invasive cervical treatment or had been previously vaccinated for HPVCytology or HPV, and colposcopy and histology
Eakin et al242018CameroonSingle dayImplementation pilot25+ years old, non-pregnant, no evidence of infection, no previous hysterectomy,
university-based population (students, faculty and staff)		VIA or VILI
Fokom Domgue et al252020CameroonApril 2016–ongoingImplementation30–65 years old, non-pregnant womenHPV
Joshi et al102013IndiaSeptember 2010–November 2011Cross-sectional21–60 years old, HIV-positive women (with serological evidence), no debilitating illness as assessed by the study clinician, intact uterus with no prolapse, no previous history of cervical neoplasiaColposcopy
Joshi et al262015IndiaOctober 2012–February 2013Cross-sectional18–60 years old, female sex workers, non-pregnant, with no history of prolapse, no history of treatment for cervical neoplasia, and having an intact uterusColposcopy
Mungo et al192020KenyaAugust 2019–Feb 2020Prospective cohort25–65 years old, HIV-positive, non-pregnant, no history of cervical cancer or precancer treatmentHPV
Naud et al222016BrazilMarch 2012–October 2019Retrospective cohortNot reportedColposcopy and histology
Pinder et al112020ZambiaAugust 2017–January 2019Prospective, unblinded, randomised control trial, pilot25+ years old, non-pregnant, no previous treatment to the cervix for any reason, no genital tract cancerVIA
Sandoval et al202019HondurasOver a period of 5 months–30–49 years old, non-pregnant, pre-menopausal womenHPV and VIA
Viviano et al212017CameroonJuly 2015–December 2015Prospective study30–49 years old, non-pregnant, no previous total hysterectomyHPV (self-sampling), and VIA for some
Zhao et al122021ChinaApril 2017–April 2019–20–65 years old, non-pregnant, no history of treatment for cervical lesionsHPV (self-sampling), colposcopy
Zhao et al272020ChinaJune 2017–unknownProspective study30–65 years old, non-pregnant, intact cervix and ever sexually active, excluded those with debilitating disease or with history of treatment for premalignant or malignant cervical lesionsHPV (self-sampling), colposcopy

  • HPV, human papillomavirus; TA, thermal ablation; VIA, visual inspection with acetic acid; VILI, visual inspection with Lugol’s iodine.